Last reviewed · How we verify

NCT06852378

Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

Recruiting now Last updated 4 March 2025
What this trial tests

trial testing Iliopsoas nerve block in Iliopsoas Nerve Block in 80 participants. Currently enrolling.

Timeline
1 March 2025
Primary endpoint
1 February 2026
1 February 2026

Quick facts

Lead sponsorAin Shams University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment80
Start date1 March 2025
Primary completion1 February 2026
Estimated completion1 February 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 65, any sex, with Iliopsoas Nerve Block or Femoral Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Iliopsoas nerve block

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06852378.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing